Are we there yet ? No, not yet, but getting really,

New Post Public Reply Private Reply Replies (1) Message Board
WBeacham
785
Are we there yet ?

No, not yet, but getting really, really close.

For the 2nd qtr 2021 it looks like we have a 3-fold increase in revenue from 1st qtr 2021, at a minimum (TAZZER, post #269042 on i-flub). This is coming on the heels of "... Q4 2020 revenue exceeded $519,000; an increase of 241% when compared to Q3 2020 revenue of ($151,956) aaaannnd reread this ... https://www.bielcorp.com/bioelectronics-corpo...forecasts/.

As Srinsocal (on i-flub, post #269087) has pointed out, this does not include any shipments to the Rest-of-the-World (ROW), eg - Europe & Asia. The CE Mark was re-certified on 12 Nov 2020, opening up sales to 33+ countries in Europe alone. It also obtained MDSAP certification in Q1 2021, which allows for product distribution in Canada, Australia, and New Zealand.

I reckon we get an update on the current situation in the week of 12 July, at the latest (11 days b4 the Olympics), however don't be surprised if it comes sooner. Or maybe some actual news, in addition to an update?!?!?! I am presuming these 2nd qtr 2021 revenue #'s (US & ROW) will make us profitable for the first time. The only thing better than that would be insurance coverage but all good things come to those who wait, right? Investors w/ any sense will want in on this in a very big way. Well, maybe not the 40 cent crowd, BBwwwaaaahaaahaaaaa !!!

Big Pharma (BP) has long arms, deep pockets, a nasty temper and is well-connected. They don't tolerate nor have any patience with upstarts or new-fangled gadgets that don't fit into their agenda (lots of examples). Like it or not, believe it or not, the FDA, in all of its self-imposed officialdom, is a wholly-owned subsidary of Big Pharma. It was created, in the first place, to act as an official cover for their drug concoctions; to give them an imprimatur of legitimacy. There is nobody who wants to believe otherwise more than myself. Look at who has headed the agency from day one to get verification or at the many of the so-called 'scandals' spanning decades. There are few, if any, 'mistakes' or 'poor decision-making'. The current opioid crisis is a prime example.

The medical field is loathe to innovation (again, lots of examples) unless it involves more pharmaceuticals, expensive surgeries, and more drugs, that's a given. The AMA took care of that decades ago with their decision to limit medical care to pills and surgery w/ few exceptions. Look up Morris Fishbein for an education. Not Wikipedia, dig a little deeper. As the saying goes - the truth is out there ... hint: it is well camouflaged and buried. The very same goes for the vaccine industry which has one of the most sordid histories one could ever imagine.

The point in bringing up all this unpleasant history is to put forth, perhaps, a more plausible backstory to our full body musculo-skeletal clearance. It would not have happened unless Big Pharma gave us, in the very least, a head nod, for it to go forward. Think of it as the 'Capo dei Capi' sanctioning, giving permission, so to speak, for it to proceed. Even gangsters can read the handwriting on the wall, to profit from societal trends. This 'go-ahead' has opened up everything and makes all things possibe going forward. In other words, we are on our way. Yes, I am including the real possibility of a buyout; post-profit and post-insurance coverage, of course.

If the decision had been made on the merits of the science and tech alone, we would have been cleared ten (10) yrs earlier, as it was in Canada. I mean, honestly, we got turned down b/c it worked better on one gender vs the other ??? It'd be laughable if it weren't so tragic. In today's world, that kind of malicious folderol passes for science. The ugly truth is BP had not made enough blood money on their opioid products. Opioid comes from Opium (ref: heroin). They knew all along, right from the gitgo, what they were doing.

Andy Whelan gave his life for (t)his company; that's commitment. He knew what so many of us now know. PEMF, and all of its' derivative technologies, is the future of medicine. Having the ability to 'see' the future in any given endeavor is the key to success. Our Founder, Andy, is still with us in spirit and enjoying every moment of it. His daughter, Kelly, our CEO, is soldiering on, doing all she can to further and enhance his legacy. Of this I have no doubt whatsoever, despite the ranting and raving of a few malcontents, nevermind their suspect motivations.

Electro-Magnetism (E/M) is THE key to everything. The Powers-That-Be w/in the BP community have known for decades the beneficial effect E/M has on the human body, including the brain. Actipatch (vibrational therapy) is but one example as are acupuncture, infrared saunas, and yoga. Western medicine, doled out to the masses that is, has always looked to overcome and conquer the body w/ drugs and surgery for obscene profits and marginal results. Far better to work with the body's own defenses and neural networks. Healthier outcomes, less disease & discomfort. Electroceuticals is the new paradigm and BP knows it better than most. Medical companies investing 100s of millions, all within about 5 yrs, is not a random event.

https://seekingalpha.com/instablog/21922151-b...onal-trial
Quote:
" ... Electroceuticals — The Next Billion Dollar Bioelectric Market

Electroceuticals are an exciting new area of therapeutics being pioneered by a growing list of companies. This rapidly growing market is projected to reach USD 33.14 billion by 2025, growing at a CAGR of 7.67% according to Kenneth Research.

As Time Magazine speculates, “Even with the still rudimentary efforts at stimulating some of the larger nerves in the body to treat, for example, headaches and chronic pain, financial analysts expect the market to reach $7 billion by 2025... "

Chakras, meridian lines, energy clusters, Hinduism third eye are concepts elusive to grasp. But we inflate a football with air we cannot see. So the air doesn't exist? We choose to believe one but not the others. How does acupuncture work? Should you decide to investigate E/M (inside and outside the human body) you will discover some very interesting info that could potentially rock your foundation to the core. Or is Plato's Cave your permanent home?

"The future belongs to those who recognize opportunities before they become obvious" - Oscar Wilde. We are the right company with the right e/m products in the right place at the right time. It is about to become very, very obvious.

I'm liking our chances - WBeacham
1

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beverly Hills MD's Dermal Cream Wins Key Beauty Award

Updated Category News Views 2

A Surprise Win in the Beauty World Who doesn't love an underdog story, right? Beverly Hills MD has slid into the limelight with their Dermal Repair Complex snagging the award for 'Beauty Product of the Year.' Talk about sending shockwaves through the beauty industry! Now, these guys might not be a household name yet, but you better believe they've got everyone's attention...

Continue Reading
Curaleaf Expands in Florida Amid Rising Cannabis Demand

Updated Category News Views 1

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...

Continue Reading
AI Platform Suno Sued for Exploiting Artists' Identities

Updated Category News Views 1

AI and the Music Business: A Legal Storm Brews Well, it looks like the music world’s hitting a rough patch with AI in the crosshairs. We've got Korein Tillery, a heavyweight in the legal arena, throwing down the gauntlet against Suno, an AI music-generation platform. Folks, welcome to the battleground where art meets tech and identity theft takes a whole new meaning....

Continue Reading
Rackspace Lawsuit Deadline: Investors Must Take Action

Updated Category News Views 2

Rackspace's Legal Predicament: Time for Action Alright folks, if you're holding shares of Rackspace Technology (NASDAQ:RXT), it’s time to sit up and pay attention. This is about more than bad PR or a temporary hiccup in the stock price—this is serious business. We’ve got until September 28, 2026, to decide if we’re in or out on this class action lawsuit train....

Continue Reading
Clinical Trials Services Market Set for Big Growth

Updated Category News Views 0

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Continue Reading
Art and Science Blend in Dr. De La Cruz's Approach

Updated Category News Views 2

Redefining Aesthetic Surgery: An Artistic Approach The world of plastic surgery is often seen through the lens of beauty and symmetry, but for Dr. Emmanuel De La Cruz, it's like staring into a whole different universe. This Houston-based plastic surgeon isn't just removing fat—he's reshaping the human canvas with the eye of a sculptor. Beyond the Standard Cut and Snip...

Continue Reading
IVD Study Success: Hybrid Monitoring Boosts Oversight

Updated Category News Views 1

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

Continue Reading
CAPR Faces Lawsuit and FDA Delay: Investor Alert

Updated Category News Views 1

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Continue Reading
Orbis Celebrates 20 Years of Eye Care in Macau

Updated Category News Views 2

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Continue Reading
Faruqi & Faruqi Urge Wix Investors to Act Now

Updated Category News Views 3

Ticking Clock for Wix Investors' Legal Moves The buzz in the stock market is louder than a bull on Wall Street, especially if you're tangled up with Wix.com Ltd. (NASDAQ: WIX). We've got Faruqi & Faruqi, LLP laying down serious advice: move fast or maybe lose your spot in line. The deadline to noodle over your position as a lead plaintiff in their federal securities class...

Continue Reading

Top 5 Most Recently Viewed Articles

Executive Shifts at Title Resources Group: Key Leadership Updates

Updated Category News Views 233

Leadership Changes at Title Resources Group Title Resources Group (TRG), a leading title insurance underwriter, is undergoing an important executive transition. Kevin Wall is set to be appointed as the new Chief Executive Officer (CEO), succeeding J. Scott McCall, who will transition to the role of Vice Chairman of the Board of Directors. This strategic move, reflecting...

Continue Reading
Bear Stewart Recall: Soy Allergy Alert Shakes Confidence

Updated Category News Views 56

Undeclared Ingredients: Not Just Another Casual Glitch Well, here we go again. Bear Stewart LLC's latest revelation sends alarm bells ringing for anyone with a nose for allergic disorders. Their Bakr Brown Butter Chocolate Chunk Ready To Bake Cookie Dough found its way to store shelves with an ingredient that can cause mayhem for many – soy. Imagine thinking you’re...

Continue Reading
Exploring the Impact of Inclusivity in Global Advertising

Updated Category News Views 134

The Importance of Inclusive Advertising In today's dynamic advertising landscape, inclusivity plays a critical role in how brands connect with their audiences. Inclusivity isn't just a buzzword; it's becoming essential for brands aiming to resonate with diverse demographics, reflecting the world we live in. XR Extreme Reach, a leading global technology company, has taken...

Continue Reading
Suburban Propane Partners with Local Organizations for Community Support

Updated Category News Views 117

Suburban Propane's Commitment to Community Well-being Suburban Propane Partners, L.P. (NYSE: SPH), a leading provider of propane and renewable energy solutions, is dedicated to making a positive impact in local communities. Recently, they partnered with Sharing House, a community organization focused on assisting those in need. This collaboration aimed to gather essential...

Continue Reading
GoHealth Inc. Achieves New Heights with Stock Performance

Updated Category News Views 227

GoHealth's Significant Stock Surge Recently, GoHealth Inc. (GOCO) has made headlines as it reached a remarkable milestone by hitting a 52-week high of $14.94. This achievement illustrates a substantial 12% gain over the past week and a phenomenal 40% surge over the last six months. Investors and market analysts have been captivated by these developments, considering the...

Continue Reading